Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/8/1343/318679/mdi251.pdf
Reference31 articles.
1. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease;Pedersen-Bjergaard;N Engl J Med,1982
2. Acute myeloid leukemia following treatment of Hodgkin's disease: a review;Grunwald;Cancer,1982
3. Two different classes of therapy-related and de-novo acute myeloid leukemia?;Pedersen-Bjergaard;Cancer Genet Cytogenet,1991
4. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project experience;Smith;J Clin Oncol,2003
5. Acute monocytic or myelomonocytic leukemia with balanced chromosomal translocations to band 11q23 after therapy with 4-epidoxorubicin and cisplatin or cyclophosphamide for breast cancer;Pedersen-Bjergaard;J Clin Oncol,1992
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Protective Effect of GnRH Agonist Triptorelin on the Histomorphometric Parameters of the Utero-ovarian Tissue in the Doxorubicin- and Cyclophosphamide-treated Mice;Cell Biochemistry and Biophysics;2024-09-08
2. Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report;Leukemia Research Reports;2024
3. Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy;Nature Communications;2018-07-04
4. Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC);Surgical Oncology;2016-09
5. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer;Breast Cancer Research and Treatment;2015-10-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3